Document:

INTERPACE
DIAGNOSTICS GROUP, INC. 2019 EQUITY INCENTIVE PLAN

 

STOCK
OPTION GRANT NOTICE AND

STOCK
OPTION AGREEMENT

 

Interpace
Diagnostics Group, Inc., a Delaware corporation (the “Company”), pursuant to its 2019 Equity Incentive Plan,
as amended from time to time (the “Plan”), hereby grants to the individual listed below (“Participant”)
an option to purchase the number of Shares set forth below (the “Option”). The Option is subject to the terms
and conditions set forth in this Stock Option Grant Notice (the “Grant Notice”), the Stock Option Agreement
attached hereto as Exhibit A (the “Agreement”) and the Plan, each of which is incorporated herein by
reference. Unless otherwise defined herein, the terms defined in the Plan shall have the same defined meanings in this Grant Notice
and the Agreement.

 

	Participant:	[_________]
	 	 
	Grant
    Date:	[_________]
	 	 
	Exercise
    Price Per Share:	[_________]
	 	 
	Total
    Number of Shares Subject to Option:	[_________]
	 	 
	Expiration
    Date:	[_________]
	 	 
	Type
    of Option:	[  ]
        Incentive Stock Option

        [  ]
        Non-Qualified Stock Option

	 	 
	Vesting
    Schedule:	1/3
    of the Option shall vest on each of the first three anniversaries of the Grant Date

 

By
Participant’s signature below, Participant agrees to be bound by the terms and conditions of the Plan, the Agreement and
the Grant Notice. Participant has reviewed the Agreement, the Plan and the Grant Notice in their entirety, has had an opportunity
to obtain the advice of counsel prior to executing the Grant Notice and fully understands all provisions of the Grant Notice,
the Agreement and the Plan.

 

	interpace
    diagnostics group, INC.	 	participant
	 	 	 	 	 
	 	 	 	 	 
	Name: 	Jack
    Stover       	 	Name: 	                   
	Title:	CEO	 	 	 

 

    	 	 	 

    	 

    

 

EXHIBIT
A

TO
STOCK OPTION GRANT NOTICE

 

STOCK
OPTION AGREEMENT

 

Pursuant
to the Grant Notice to which this Agreement is attached, the Company has granted to Participant an Option under the Plan to purchase
the number of Shares set forth in the Grant Notice.

 

1.
Award of Option. In consideration of Participant’s past and/or continued employment with or service to the Company
and for other good and valuable consideration, effective as of the Grant Date set forth in the Grant Notice, the Company has granted
to Participant the Option to purchase any part or all of the aggregate number of Shares set forth in the Grant Notice, upon the
terms and conditions set forth in the Grant Notice, the Plan and this Agreement.

 

2.
Date of Grant; Term of Option. The Option is granted on the Grant Date and may not be exercised later than the Expiration
Date, subject to earlier termination in accordance with the Plan and this Agreement.

 

3.
Option Exercise Price. The exercise price per Share of the Shares subject to the Option (the “Exercise Price”)
shall be as set forth in the Grant Notice.

 

4.
Vesting and Exercise of Option. The Option will become vested and exercisable only in accordance with the terms and provisions
of the Plan and this Agreement, as follows:

 

(a)
Vesting. Subject to the continued service of the Participant by the Company through the relevant vesting dates, the Option
shall become vested and exercisable in such amounts and at such times as are set forth in the Grant Notice.

 

(b)
Service with Affiliates. Solely for purposes of this Agreement, service with the Company will be deemed to include service
with any Affiliate of the Company (for only so long as such entity remains an Affiliate of the Company).

 

(c)
Effect of Termination of Service on the Option.

 

(i)
Forfeiture of Unvested Option. If the Participant’s service terminates or is terminated for any reason, the unvested
portion of the Option shall be forfeited immediately with no further compensation due to the Participant.

 

(ii)
Vested Portion of the Option. If the Participant’s service terminates or is terminated for any reason, the vested
portion of the Option shall remain exercisable for such period as set forth in Section 7 of the Plan.

 

(d)
Method of Exercise. The Participant may exercise the Option by delivering a written notice of exercise to the Company in
accordance with Section 5(d) of the Plan.

 

(e)
Partial Exercise. The Option may be exercised in whole or in part; provided,
however, that any exercise may apply only with respect to a whole number of Shares.

 

(f)
Restrictions on Exercise. The Option may not be exercised, and any purported exercise will be void, if the issuance of
Shares upon such exercise would constitute a violation of any law, regulation or exchange listing requirement. The Board may from
time to time modify the terms of the Option or impose additional conditions on the exercise of the Option as it deems necessary
or appropriate to facilitate compliance with any law, regulation or exchange listing requirement. As a further condition to the
exercise of the Option, the Company may require the Participant to make any representation or warranty as may be required by or
advisable under any applicable law or regulation.

 

    	 	A-1	 

    	 

    

 

5.
Non-Transferability of Option. The Option may not be sold, pledged, assigned, hypothecated, gifted, transferred or disposed
of in any manner either voluntarily or involuntarily by operation of law or otherwise, other than by will or by the laws of descent
and distribution.

 

6.
Investment Representations. The Participant represents and warrants to the Company that the Participant is acquiring the
Option (and upon exercise of the Option, will be acquiring Shares) for investment for the Participant’s own account, not
as a nominee or agent, and not with a view to, or for resale in connection with, any distribution thereof. As a further condition
to the exercise of the Option, the Board may require that certain agreements, undertakings, representations, certificates, legends
and/or information or other matters, as the Board may deem necessary or advisable, be executed, agreed to and/or provided to the
Company to assure compliance with all such applicable laws or regulations.

 

7.
Tax Consequences. The Participant acknowledges that the Company has not advised the Participant regarding the Participant’s
income tax liability in connection with the grant of the Option and that the Company does not guarantee any particular tax treatment.
The Participant acknowledges that the Participant has reviewed with the Participant’s own tax advisors the tax treatment
of the Option (including the purchase and sale of Shares subject hereto) and is relying solely on those advisors in that regard.
The Participant understands that the Participant (and not the Company) will be responsible for the Participant’s own tax
liabilities arising in connection with the Option.

 

8.
No Continuation of Service. Neither the Plan nor this Agreement will confer upon the Participant any right to continue
in the employment or service of the Company or any of its Affiliates, or limit in any respect the right of the Company or its
Affiliates to discharge the Participant at any time, with or without Cause and with or without notice.

 

9.
Withholding. The Company is hereby authorized to withhold from any consideration payable or property transferable to the
Participant any taxes required to be withheld by applicable law in connection with the grant, vesting or exercise of the Option
or the disposition of the Shares subject to the Option.

 

10.
The Plan. The Participant has received a copy of the Plan, has read the Plan and is familiar with its terms, and hereby
accepts the Option subject to the terms and provisions of the Plan. Pursuant to the Plan, the Board is authorized to interpret
the Plan and to adopt rules and regulations not inconsistent with the Plan as it deems appropriate. The Participant hereby agrees
to accept as binding, conclusive and final all decisions or interpretations of the Board with respect to questions arising under
the Plan, the Grant Notice or this Agreement.

 

11.
Entire Agreement. The Grant Notice and this Agreement, together with the Plan, and any other exhibits attached hereto,
represents the entire agreement between the parties with respect to the subject matter hereof and supersedes any prior agreement,
written or otherwise, relating to the subject matter hereof.

 

12.
Amendment. Except as otherwise provided herein, in the Grant Notice or in the Plan, or as would otherwise not have a material
adverse effect on the Participant, this Agreement may only be amended by a writing signed by each of the parties hereto.

 

13.
Governing Law. This Agreement will be construed in accordance with the laws of the State of Delaware, without regard to
the application of the principles of conflicts of laws.

 

    	 	A-2	 

    	 

    

 

14.
Execution. The Grant Notice may be executed, including execution by facsimile signature, in one or more counterparts, each
of which will be deemed an original, and all of which together shall be deemed to be one and the same instrument.

 

15.
Incentive Stock Options. Participant acknowledges that to the extent the aggregate
Fair Market Value of Shares (determined as of the time the option with respect to the Shares is granted) with respect to which
Incentive Stock Options, including the Option (if applicable), are exercisable for the first time by Participant during any calendar
year exceeds $100,000 or if for any other reason such Incentive Stock Options do not qualify or cease to qualify for treatment
as “incentive stock options” under Section 422 of the Code, such Incentive Stock Options shall be treated as Non-Qualified
Stock Options. Participant further acknowledges that the rule set forth in the preceding sentence shall be applied by taking the
Option and other stock options into account in the order in which they were granted, as determined under Section 422(d) of the
Code and the Treasury Regulations thereunder. Participant also acknowledges that an Incentive Stock Option exercised more than
three months after Participant’s termination of service, other than by reason of death or disability, will be taxed as a
Non-Qualified Stock Option.

 

16.
Notification of Disposition. If the Option is designated as an Incentive Stock Option,
Participant shall give prompt written notice to the Company of any disposition or other transfer of any Shares acquired under
this Agreement if such disposition or transfer is made (a) within two years from the Grant Date or (b) within one year after the
transfer of such Shares to Participant. Such notice shall specify the date of such disposition or other transfer and the amount
realized, in cash, other property, assumption of indebtedness or other consideration, by Participant in such disposition or other
transfer.

 

    	 	A-3Exhibit

Exhibit 10.1
Non-Employee Director Compensation
The following is a summary of the retainers payable to non-employee directors effective January 1, 2020:	
		
	Retainers
	 

	Annual Board Retainer
	$125,000

	Annual Retainers (in addition to Annual Board Retainer):
	 

	Independent Chairman of the Board
	$75,000

	Audit Committee Chair
	$30,000

	Compensation and Management Development Committee Chair
	$30,000

	Corporate Governance Committee Chair
	$30,000

	Audit Committee Member (other than Chair)
	$15,000

	Compensation and Management Development Committee Member (other than Chair)
	$15,000

	Corporate Governance Committee Member (other than Chair)
	$15,000

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00300-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00300-of-00352.parquet"}]]